Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics

Trending on Bing

Freed from detention
Judge halts Trump’s plan
Court blocks Louisiana law
Trump can keep control
China sends scores of planes
Says he was run off the road
Chocolates recalled
Alleged bomb threat probe
16 billion passwords leaked
Teen struck by lightning
On ICE raids at hotels, farms
Chinese student sentenced
Activists damage UK planes
DEA informant charged
Breaks hip in crash
To retire from figure skating
Brown pleads not guilty
Calls for special prosecutor
Falling rocks hit hikers
Russian attack on Odesa
‘Hee Haw’ actor dies
Refuses to expedite challenge
UK assisted dying bill
Allows firms to pick courts
Revives terror victim suits
Says July rate cut possible
Voice of America layoffs
Deezer adds AI song tags
Former TN state senator dies
Signing with Winnipeg Jets
Buys minority stake in PSG
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Gene Therapy, Sarepta and After Death

Barron's on MSN · 4d
Sarepta Stock Plunges After Death of Second Patient Receiving Its Gene Therapy
A second patient receiving its experimental gene therapy Elevidys has died from liver failure, raising serious questions on the drug’s outlook.
BioSpace · 4d
UPDATE: Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys
Sarepta’s shares crashed 41% in premarket trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.
Associated Press News on MSN · 4d
Second patient death reported with gene therapy for muscular dystrophy
Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
BioSpace
2d
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
Managed Healthcare Executive
4d
Sarepta Stops Shipments of Elevidys For Non-Ambulatory DMD Patients
A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy